Stay updated with breaking news from Erina gillaspie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jason Porter, MD, highlights the implications of recent data to emerge following the use of EGFR TKIs in the adjuvant setting, the importance of the potential upcoming FDA approval of osimertinib with chemotherapy in EGFR-positive non–small cell lung cancer, and more. ....
Specialists discuss unmet needs that continue to exist in treating patients with NSCLC despite advances in treatment, and how these impact patient outcomes. ....